|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
) U$ d6 z/ K1 Y& @& p. a: W% V" A$ U, B/ a
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
: ^9 q1 T# |0 n& {, O; d0 w7 W2 I
9 m5 u+ j3 H J5 _) X' i& K' _头颈肿瘤BU入选ASCO 2025的研究8 ^ k: i$ f, C( b
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.' I5 m7 s {- v* C$ a
肿瘤内科-头颈肿瘤科姜愚团队
8 N& X2 f+ i6 Q" q8 U2 S" _; w* ^- h' [
Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.* L- _! A# @2 S/ h
肿瘤内科-头颈肿瘤科刘磊团队# c! a6 U9 q% ^2 ]
8 x5 ~! h8 @% C8 N, oA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
0 k7 t# P- B+ c8 a肿瘤内科-头颈肿瘤科刘磊团队8 {, d( o2 l! U* ]6 E- V
! k: ^2 C9 w% I7 a BA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy. X1 U3 c3 ?% K" [4 _
肿瘤内科-头颈肿瘤科刘磊团队" V4 k: D# y7 i5 T# p0 R
" t+ ]6 B6 Y- x/ Z& _
ribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
- q* ~: g5 q& \肿瘤内科-头颈肿瘤科姜愚团队$ H+ K7 H9 u |5 i5 {, ~) u$ g
|
|
[复制链接]
发表于 2025-5-2 09:58:22
